Cargando…
Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer
BACKGROUND: CD3 + and CD8 + T-cell infiltration were reported as positive predictive markers of survival in colorectal cancer (CRC) patients. Here, we demonstrate the prognostic significance of CD4 + and FOXP3 + T-cell densities in CRC. METHODS: We quantified the intratumoural densities of CD3 + ,...
Autores principales: | Kuwahara, Taichi, Hazama, Shoichi, Suzuki, Nobuaki, Yoshida, Shin, Tomochika, Shinobu, Nakagami, Yuki, Matsui, Hiroto, Shindo, Yoshitaro, Kanekiyo, Shinsuke, Tokumitsu, Yukio, Iida, Michihisa, Tsunedomi, Ryouichi, Takeda, Shigeru, Yoshino, Shigefumi, Okayama, Naoko, Suehiro, Yutaka, Yamasaki, Takahiro, Fujita, Tomonobu, Kawakami, Yutaka, Ueno, Tomio, Nagano, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889292/ https://www.ncbi.nlm.nih.gov/pubmed/31488881 http://dx.doi.org/10.1038/s41416-019-0559-6 |
Ejemplares similares
-
Correction: Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer
por: Kuwahara, Taichi, et al.
Publicado: (2019) -
CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision rule
por: Nakagami, Yuki, et al.
Publicado: (2022) -
Cetuximab strongly enhances immune cell infiltration into liver metastatic sites in colorectal cancer
por: Inoue, Yuka, et al.
Publicado: (2017) -
Determining the protective characteristics and risk factors for the development of anastomotic leakage after low anterior resection for rectal cancer
por: Suzuki, Nobuaki, et al.
Publicado: (2020) -
Siglec-7 is a predictive biomarker for the efficacy of cancer vaccination against metastatic colorectal cancer
por: Yamada, Kensuke, et al.
Publicado: (2021)